UK

NHS (UK) Fast Tracks Chemotherapy for Men Who Are Still Hormone Sensitive

One of the frustrations faced by men in the UK has been the Guideline that restrictes the use of chemotherapy (docetaxel) to only men who have already failed hormone therapy (ADT). This Guideline directly contradicts the current, cutting edge evidence that, in certain circumstances, earlier chemotherapy increases survival. The good news is that the NHS [...]

By Malecare|2016-01-25T11:47:41-05:00January 25th, 2016|ADT, Advanced Prostate Cancer, Chemotherapy, Combination Therapy, docetaxel, Drugs & Treatments, Hormone Therapy, NHS, Survival, Uncategorized, United Kingdom - England, Northern Ireland, Scotland & Wales|0 Comments

About the Important Genetic Prostate Cancer Study (UKGPCS) in the United Kingdom

Cancer is a genetic disease, so prostate cancer is a genetic problem. This statement might be the most important one we can make when trying to describe the current, overall situation we face as prostate cancer survivors! Many institutions have begun significant research studies trying to understand the actual genetic keys to prostate cancer. Prostate [...]

By Malecare|2020-02-04T12:38:20-05:00December 7th, 2015